<SEC-DOCUMENT>0001213900-25-077495.txt : 20250815
<SEC-HEADER>0001213900-25-077495.hdr.sgml : 20250815
<ACCEPTANCE-DATETIME>20250815163023
ACCESSION NUMBER:		0001213900-25-077495
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20250815
DATE AS OF CHANGE:		20250815

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NEUROONE MEDICAL TECHNOLOGIES Corp
		CENTRAL INDEX KEY:			0001500198
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				270863354
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-279871
		FILM NUMBER:		251225101

	BUSINESS ADDRESS:	
		STREET 1:		7599 ANAGRAM DR
		CITY:			EDEN PRAIRIE
		STATE:			MN
		ZIP:			55344
		BUSINESS PHONE:		(952) 426-1383

	MAIL ADDRESS:	
		STREET 1:		7599 ANAGRAM DR
		CITY:			EDEN PRAIRIE
		STATE:			MN
		ZIP:			55344

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Original Source Entertainment, Inc.
		DATE OF NAME CHANGE:	20100830
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>ea0253345-424b5_neuroone.htm
<DESCRIPTION>PROSPECTUS SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed pursuant to Rule 424(b)(5)<BR>
Registration No. 333-279871</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps"><B>Prospectus Supplement</B></FONT><B><BR>
(To the Prospectus Supplements dated April 3, 2025 and August 16, 2024)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(To the Prospectus dated August 16, 2024)</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="width: 380px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NeuroOne Medical Technologies Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>$6,750,000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus supplement supplements the prospectus
supplements dated August 16, 2024 and April 3, 2025 (the &ldquo;Prior ATM Prospectus Supplement&rdquo;), to the prospectus dated August
16, 2024 (the &ldquo;Base Prospectus&rdquo; and, together with the Prior ATM Prospectus Supplement, the &ldquo;Prior Prospectus&rdquo;),
relating to the offer and sale of shares of our common stock, par value $0.001 per share, having an aggregate offering price of up to
$4.7 million from time to time through JonesTrading Institutional Services LLC (&ldquo;Jones&rdquo;), as sales agent, in &ldquo;at the
market offerings&rdquo; (as defined in Rule 415 promulgated under the Securities Act of 1933, as amended) pursuant to a Capital on Demand&trade;
Sales Agreement (the &ldquo;Sales Agreement&rdquo;), dated December 21, 2022, that we entered into with Jones. As of the date hereof,
we have sold an aggregate of approximately $8,000,600 pursuant to the Sales Agreement under the Prior Prospectus. We are filing this prospectus
supplement to supplement the Prior Prospectus to increase the amount of shares registered that we are eligible to sell pursuant to the
Sales Agreement to $6,750,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This
prospectus supplement should be read in conjunction with the Prior Prospectus, and is qualified by reference to the Prior Prospectus in
all respects, except to the extent that the information presented herein supersedes the information contained in the Prior Prospectus.
This prospectus supplement is not complete without, and may only be delivered or used in connection with, the Prior Prospectus, including
any amendments or supplements thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is listed
on The Nasdaq Capital Market, or Nasdaq, under the symbol &ldquo;NMTC.&rdquo; On August 14, 2025, the last reported sale price of our
common stock on Nasdaq was $0.83 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The aggregate market value
of our outstanding common stock held by non-affiliates pursuant to General Instruction I.B.6 of Form S-3 was approximately $49.75 million,
which was calculated based on 48,301,009 shares of our outstanding common stock held by non-affiliates and a price of $1.03 per share,
which was the price at which our common stock was last sold on the Nasdaq Capital Market on July 22, 2025. During the 12 calendar months
prior to and including the date of this prospectus supplement, we have sold $9,614,037 of securities pursuant to General Instruction I.B.6
of Form S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Investing in our securities
involves a high degree of risk. See &ldquo;Risk Factors&rdquo; in the Original Prospectus and documents incorporated therein by reference
for a discussion of such risk factors, which factors should be read carefully in connection with an investment in our securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Neither the Securities
and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy
or adequacy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_002.jpg" ALT="" STYLE="width: 160px"></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Prospectus supplement dated August 15, 2025</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !! 9<# 2(  A$! Q$!_\0
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MNU=3J&HVVF64EW=2;(D')]?:N5^&G/AV;_KNU<]\1-7>\U@:<C_N+<98=BU
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M;NC^.M7TQP)9?MEMW23K^!KU^:"&:,I+$CJ>Q7->>^,/!,<5N^IZ4FPI\TL
MZ8]10!V>C:S9ZY9"ZM9,C^)#U0^E:))Y]*\1\,ZU)HFLPSHQ\B0A)5[,#WKV
MPLKQAE(*D9!]:3!;GD'Q$U5KW7A9*_[JU7IZL:X\GCN17<:GX!UV]U6ZNM\&
M)9"RY;M3=/\ AUJBZC;O<F P*X9P#VKS9TISGJ?78;&4:%#E3U-GP3X/BAMD
MU&_B#W#_ #(A'"#U^M>@HH5=J@8%,AC$*!0!Z5,!Q7?""@CYG$5Y5IN4F(!U
MXZUBZUH,6I1,ZA4N!]UQW^M;=!/I6T9.+NCCG%2T9Y.Z-$[(ZX=3A@>QJ[HU
MX;'58)0?E8[&'J#6[K'AFYN]2DGMC&J2#)R>]4!X2U($?-%D'/WJ]%U83A9L
MX%3E&>B.JUS5/['T6XU'891"F[8#C->:K\:5(!_L=N?^FE=KXR5D\#7RN1N$
M&#BOG-#^[7Z4L)AXU;W%BJ\H6L>Y>&?B9'X@U&2TDLOLL<<1D:9I.% K#U[X
MP2K.\.B6RLBG'GS?Q?05Y8DKH&\MW4.-K!>_M6Y:>"_$=[:B>WTJ7RB,KNXS
M]*Z982C3E>3.;ZU5G'0UU^*GB@2%C);8/\/E5UGAGXM17MS%9ZS +9Y#M6=3
M\A/OZ5Y)<VUQ97#VUU"\$R_>1Q@U 1D$<\^GK6T\)2G"\$90Q52,O>9]9(X=
M0P.0>0?6FR2+&K,S;549)/2N4^'&L/J_@^T>5BTT/[IR>^*Y'XK>+9EE70+&
M4H"NZZ=3SCLM>+"@W4Y#V)5TH<QJ^(?BQINFS-:Z;";Z5>"X.$!^O>N.G^+7
MB.5OW*VT2^FS.*X0;57(X _2NY\-?#/4M>M$O+F;[%;N,Q@KEV'KBO5^KT*,
M;S/,^L5:KM =;_%KQ'$X,J6TR=QMQFNV\.?%;3=5F2VOT^PW#'"ECE"?3-<?
MK_PHU'2[-[NPNOMJQC<T17:V/;UKSXX(PV?H1R*2H4*Z?(/V]:D_>/K)&#<@
MY!Y'-%>7?"KQ7+>PR:%?2EYH%W0.QY*>GX45Y%2FX2Y3U:=:,XW.*/;_ 'A_
M.O?[#_D'6W_7)?Y5X >W^\/YU] :>,Z=;?\ 7)?Y5F;F-XI\,0>(+/@".\C'
M[J7^AKR,K?:+J>"'M[RW?J/\]*]](P*YKQ7X8AU^U+H E]&/W4@_B_V30 [P
MKXHA\06FQR([V,?O(_7_ &A7!?$#_D;)/^N2UAH]]HNJ[EWV]Y;MR/7V^E6=
M?U?^W-26^,?ENT:JX'J* ._^&?'AV;_KLU>>:[+]HU_49#SF9AFO1/AH/^*=
MF_Z[-7GGB&W:V\0:A"1@B9C^= %G3O%VK:59K9VDL21*3@&/-6O^%@^(!_R\
M1_\ ?JNW\(6>EZAX:M)39P/(J[')0$Y'K6\-$TLC_D'VW_?L4 >5?\+!\0?\
M_$7_ 'ZK!O;V34+N6ZN"#++RQ"X%>YG1=+ _Y!]M_P!^Q4']G:-Y_P!G^R6G
MG8W>7L&<4 9O@"7SO"=OSG:S+^M<O\3O^0I8_P#7)OYUZ1;V\%M%Y=O"D29^
MZHP,UYQ\30?[1T]SWC8?K0!/\+O]?J/_  &O2:\S^%[J+O4$)Y*J:]+S0 U_
MN-]#7S_J/_(0O/\ KLW\Z]^E)6)R>RGFOG^[;?>73=C*Q_6@#W/0?^1?L/\
MK@O\JYWXF?\ (MQ_]=U_D:Z+001X?L >OD+_ "KG?B9_R+D?_7=?ZT <9X&4
M-XOM<]E)KV<<BO&O 7_(W0?[C5[+0 AKR3XBS-)XG$1/RQ1  ?7FO6S7DWQ(
MMGB\113D?)+%P?I0!T/PTLTBT2:[VCS)I,9]A7<]JX+X:7Z/IEQIY;$D+[P/
M537> Y% "TUU#HRL,JPP12DX%1RS+!"\TA"QHNYC[4 >#ZW:BRUF^MDX5)&*
MCT%>R^&YVNO#=C(Y^8Q ?E7B^K7?]H:G>7*\B:4[?IVKVOP_:FST"RA;[RQ
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M5CTTT=1\/].@U/QE:0W"AHDW2%3W(Z5]%*H   &/05X)\*UW>-XR/X86->_
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E*<***A[FL=AIJM-116L#FK["1]*L)THHIS(H[DHHHHK ] __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !. +T# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBLRX\0Z/:SO!/J=I%*
MAPR/,H(_#--1;V1,I1C\3L:=%9'_  E.@_\ 08L?_ A?\:/^$IT'_H,6/_@0
MO^-5[.?9D>VI_P R->BL?_A*=!_Z#%C_ -_U_P :U@X90RD$'D'UJ91<=T5&
M<9?"[CJ**YKQCXFE\,:=!<QVRSF27RR&;&."<_I50@YR48[L*E2-.+E+9'2T
M5PGA+Q_/XCUG[#)91PKY9?<KDGC'M[UW=55I2I2Y9[D4:T*T>:&P444F:R-A
M:*** "BBDH 6BBB@ HI*6@ HHHH **** $KP3Q7 ;KQY=VZL%,MPJ GH,X%>
M]]J\+UW_ )*6_P#U^Q_S6O3RUVG)^1X^:J\(KS-C_A4NHD9_M&V_)J/^%2:C
M_P!!"V_)O\*]<'045G_:-?O^!JLLP]MOQ/G7Q!H<WAW5?L,TRRL%5]RY Y^M
M?05D/]!M_P#KFO\ *O&OB=_R.+?]<4KV:RXL8/\ KFO\JWQTW.C3D]V89?!0
MK5(K9$]>??%K_D 67_7U_P"R-7H->??%K_D 67_7T/\ T!JX\%_'B=N/_P!W
MD<K\+N?%Q_Z]W_F*]KKQ3X6_\C<?^O=_YBO3?%?B2+PWI#7) >=SLAC)^\WO
M["NO,8N>)45NTCCRR<:>%<I=&:]S>VME'YES/%"G]Z1PH_6L]/%6@N^U=7LB
MWIYR_P"->%RSZOXIU8!FEN[N4G:@/ 'H!T %;%Q\-_$5O;&;R(I2!DQQR98?
MX_A5?4*4-*L[,S_M*M-MTH71[A'-',@>-U=#R&4Y!I^<"OGOP_XGU'PU?!HG
M<P[L2V[GAO7Z'WKWBROX-3TR*\MFW13)N4_T/O7)B<)*@UK=,[L+C8UT]+-$
M?]O:1G!U2RS_ -=U_P :LSWEO:P^=<3Q11?WW<*/S-?-4Q_?O_O&NL^P>(O'
MMTUW#'MM4^2/>^(T'H/4^O']*ZYY=&%FY61PPS24VXJ%V>M0^*-#GE$4>K6;
M.>@$R\_K6H&#<@Y%?/&N>&]4\/2(M]#M5_N2HV5/XUW'PO\ $=Q+</HMU(TD
M8CWP%CDKCJOT]/I45\!&-/VE*5TC7#YC*57V56-FSU&JUUJ%I8Q^9=7,,"?W
MI7"C]:Q_%_B5/#6D>> 'N93LA0]SZGV%>*K_ &QXKU? ,MY=R<^RC^0'Z5CA
ML&ZJYY.T3;%XY49<D5>1[K#XIT*>01QZM9EST'G+S^M:@8,,@Y'J*\+O_A]X
M@TZS>Z>!)40;G6)\LH^G?\,U9\#>,+G2-1AL+J8OI\K!-K'/E$\ CT&?\:VJ
M8"#@Y49<UC"GF,U-0KQY;GMN:I7NK:?IP_TV]M[?/3S9 N?SK#\=^(9?#^@>
M9;'%S.WEQMUV\<M^ _4BO&["PU/Q+JAB@WW-U)\[N[=NY)-9X;!>UBZDW9&N
M+Q_LIJG!7D>[Q>)]#G?9'JUFS'MYR@U*VBZ1<7'VQM/M))F._P TQ*6)]<UX
M]<_#;Q';1>8L,4V.T4@S^N*]3\%P36WA*PAGC>.5%8,CJ01\QZ@U->C3I14J
M4[]"L-7J5I<M6%NIN.ZQJ6<A5'4FH_MEM_SWC_[Z%97B[3+G6/#5W8V@4S2[
M=H8X'# G]!7EO_"LO$?_ #S@_P"_HJ*%&G45YSL7B,15I2M"%T)\2Y$D\7ED
M8,ODIR#]:]HL?^/"W_ZYK_*O%Q\,O$6X'RH/^_HKVJU1HK6*-L;E0 _E71C9
M4_9PA"5['-@(U/:SG.-KDU>>_%K_ )%^R_Z^A_Z U>@9KSSXM2I_8MC$2-YN
M-P'J I']17/@O]XB=6/:^KR.8^%O_(W'_KW?^8J?XJWKS>(H;7/[N"$$#_:8
MG/Z 5!\+03XM8@=+9S^HIWQ2MGB\5+,1\DT"D'W!((_3]:]AV^O:]CPU=8!^
MIO?"73HOLE]J+*#(TGDJ?0 !C_,?E7I6*\X^$M]&VG7U@6'FI*)=O<J0!_[+
M^M>D9KR,=?ZQ*Y[>7J/U>-CPWXD:?'8^+9FB7:MQ&LQ ]3D']1G\:[3X67C3
M^&;FW8D^1,0OLI /\\UQWQ,OH[OQ:R1L#]GB6(D?WLDG_P!"_2NN^%=J\7AN
M[N&&!-.=ON  /YYKT:_^Y1YM]#R</IC9<NVIY'+_ ,?#_P"\:^C=%LHM/T6S
MM8E 2.)1QW..3^?-?.4W^O?_ 'C7TO:_\>D7^X/Y5.:/W8(TRA>_-G)_$V)'
M\'RNR@M'*C*?0YQ_(FO//AP<>-;/_=D_] ->C?$O_D2[G_KI'_Z$*\Y^''_(
M[6?^Z_\ Z U&%_W.?S#&?[]#Y&C\5KMY?$4%L2?+A@! ]V)S_(?E2>!?$^B^
M&[*X-XDQNYGY9(P<(.@Z^I-+\5;1XO$<%R1\DT  /N"<_H1^=5/!?A33/$\-
MPLU[+#=1-G8FWE3T/KUS^GK6\52>#CS[>1S3=58V7)OYG<'XH>'B""MU_P!^
MQ_C7D&H26\NJ7,EJ"MN\S-$" "%)X'MQ7J7_  J33?\ H(77Y+_A0/A+IH_Y
MB%U^2_X5C0K82A=P;U.BOA\97MSI:#_&VFW6M^!["\A4R30(DS*!DE2O./T/
MTS7G/AGQ#/X:U47D4:R*R[)(V.-RY]>QR!7T#;P);6L5NOW(T"#/H!BN3U[X
M<Z1J[//;@V5PW):(?(3[K_ABL,-BX1BZ51>ZSHQ6"J.2JTG[RL7M!\;:/KQ6
M*&;R;D_\L9>&/T[&NC%?.NO:%>^&]4^R7)7< 'CD0\,/4?D:]9^'6O7.LZ$Z
M7;EY[9_+\P]67'&??M^%1BL'&$/:TW>++P>.E4G[&JK2.RI<48HKS3UQ,44M
M&* /'/&?B+5]'\9WR6%_+"A"'9D%?N+V.17&ZEJM_K%P)K^YDGD P-W;V '2
MOH:_T33-3(:]L;>=AT:2,$C\:@M/#.BV,HEMM,MHY!T81C(^AKUZ..I4XKW-
M4>'6RZM4F_?]UG)?#+PU<:;;S:G>1F.6X 6)&&&"=23Z9X_*MCQQX8_X2/21
MY&!>6Y+19XW9ZK^/'XUU04"C K@EB9RJ^UZGHQPD(T?8]#YPL[S4O#>K^;$7
MMKJ$[61Q^8(/45U-S\5-:FM3%'!;0R$8,JJ21[@$X'XUZMJ.A:7JP OK*&<@
M8#,OS#Z'J*RT\ >&8WWC3$S[R.1^1->@\;0J6E4AJ>:LOQ%.\:4]#QG1]%U'
MQ-JGE0*SN[;I9GSA>>23_G->]Z;IT.D:3#8VXQ%#'M'N>Y/N35BTL;6QA$-I
M;QP1CHD:A1^0J? -<F*Q<J[2M9([,)@E03=[R9\Q3?Z]_P#>-?2]K_QZ1?[@
M_E60?!GAXG/]E6_Y5N*@50JC ' %5C,5&NHI*UB<%@Y8=R<G>YR/Q*_Y$NY_
MZZ1_^A"O./AQ_P CK9_[LG_H!KVZ^T^UU*U:VO(5FA8@E&Z<=*HV7AC1M.ND
MN;33X8IDSM=1R,C%.CBHPH2I-:L*^#E4Q$:J>B*GB_PW'XDT<VX(2YB.^%SV
M/H?8UXD\6K>&=5Y$UG=Q'AO4>QZ$?SKZ.P*K7FG6>H1>5>6L,Z?W94##]:6&
MQCHKDDKQ'B\ JSYXNTCR"#XJ:['%MDALY6Q]]HR"?KAL5)H_C+6]>\4Z;#<7
M&R SJ3% NU3]>Y'UKT0^!_#A;<=*AS]3_C6E8Z+INF#_ $*Q@@/=D0 GZGK6
ML\3AN5\E/5F,,'BN9<]31')_$R^N].T[3[FRGDAE6X^\AQ_">OK7(6WQ2U^&
M/9*EK.0/OO&0?T(%>S36\-Q$8IHTDC;@JX!!_"L27P5X=F8LVDVX)_N K_*L
MZ&(H1AR5(7-,1A:\JG/2G8\0UC6=0\1ZD+B[(>4@(D<:X &> !]2:]?^'V@3
MZ'H)-VI2XN7\QD/51C !]^I_&MNP\.:/I;^99Z?!%)TWA/F_,\UIX%&)QBJ0
95."M$6$P#I3]K4=V+1117GGJA1110!__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
